Autosomal dominant RYR1 mutations have a variable age of onset, ranging from birth to the 6th decade of life [51] and are associated with a variable phenotypic spectrum including malignant hyperthermia susceptibility, rhabdomyolysis, proximal weakness and possibly mild facial weakness. Here, RYR1 is linked to Malignant hyperthermia.